Status | Study |
COMPLETED |
Study Name: Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome Condition: Angelman Syndrome Date: 2023-03-13 Interventions: The assay developed in this study is determined to be FDA regulated as an exempt diagnostic device.In this study, the testing involved with t |
RECRUITING |
Study Name: Study to Investigate the Pharmacokinetics and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype. Condition: Angelman Syndrome Date: 2022-11-09 Interventions: Participants aged 15-17 years or above receiving the adult 60 mg of alogabat dose.I |
Recruiting |
Study Name: Single Dose Pharmacokinetic (PK) Study Condition: Angelman Syndrome Fragile X Syndrome Date: 2017-04-06 Interventions: Drug: OV101 Single-dose 5 mg OV101 Other Name: Gabox |
Recruiting |
Study Name: A Study in Adults With Angelman Syndrome Condition: Angelman Syndrome Date: 2016-12-02 Interventions: Drug: OV101 Regimen 1 Other Na |
Completed |
Study Name: Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW Condition: Rett Syndrome Prader-Willi Syndrome Date: 2015-11-06 |
Recruiting |
Study Name: SNP-based Microdeletion and Aneuploidy RegisTry (SMART) Condition: 22q11 Deletion Syndrome DiGeorge Syndrome Trisomy 21 Date: 2015-03-02 |
Withdrawn |
Study Name: An Exploratory Open Label Study of EPI-743 (Vincerinone TM) in Children With Autism Spectrum Disorder Condition: Autism Spectrum Disorder Date: 2014-08-21 Interventions: Drug: EPI-743 Other Name: Vincerinone TM |
Completed |
Study Name: Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome Condition: Angelman Syndrome Date: 2014-02-05 Interventions: Drug: MINOCYCLINE Pill Minocyc |
Completed |
Study Name: Assessment of the Pharmacokinetics of Circadin® in Children With Neurodevelopmental Disorders and Sleep Disturbances Condition: Sleep Problems Date: 2013-07-16 Interventions: Drug: Circadin 2 mg First arm |
Active, not recruiting |
Study Name: Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities Condition: Sleep Disorders Date: 2013-07-11 Interventions: Drug: Circadin 2/5/10 mg Activ |